{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:45:20Z","timestamp":1790815520244,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32AR007176"],"award-info":[{"award-number":["5T32AR007176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.amjmed.2010.09.012","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T04:15:29Z","timestamp":1296706529000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout"],"prefix":"10.1016","volume":"124","author":[{"given":"Robert T.","family":"Keenan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria B.","family":"Crittenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Krasnokutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheongeun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Suppl 51","key":"10.1016\/j.amjmed.2010.09.012_bib1","first-page":"S115","article-title":"Gout and mortality","volume":"26","author":"Kim","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"15 Suppl","key":"10.1016\/j.amjmed.2010.09.012_bib2","first-page":"S435","article-title":"Epidemiology of hyperuricemia and gout","volume":"11","author":"Luk","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.amjmed.2010.09.012_bib3","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ajkd.2002.33911","article-title":"The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994","volume":"40","author":"Kramer","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2010.09.012_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2010.09.012_bib6","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2010.09.012_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2010.09.012_bib9","first-page":"1346","article-title":"The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China","volume":"33","author":"Nan","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2010.09.012_bib11","first-page":"1813","article-title":"Evaluation of allopurinol use in patients with gout","volume":"46","author":"Zell","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.amjmed.2010.09.012_bib12","first-page":"562","article-title":"Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system","volume":"33","author":"Mikuls","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib13","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study","volume":"33","author":"Neogi","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib14","series-title":"Goodman & Gillman's Pharmacology","article-title":"Analgesic-Antipyretic Agents: Pharmacotherapy of Gout","author":"Burke","year":"2006"},{"key":"10.1016\/j.amjmed.2010.09.012_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-62-4-639","article-title":"The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout","volume":"62","author":"Klinenberg","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2010.09.012_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002512-200724010-00002","article-title":"Management of gout in older adults: barriers to optimal control","volume":"24","author":"Hoskison","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjmed.2010.09.012_bib17","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2174\/1381612053764922","article-title":"Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors","volume":"11","author":"Cheng","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.amjmed.2010.09.012_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-007-0020-3","article-title":"Cardiovascular risk, hypertension, and NSAIDs","volume":"9","author":"White","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.amjmed.2010.09.012_bib19","series-title":"Goodman & Gillman's Pharmacology","article-title":"Adrenocorticotropic Hormone: Adrenocortical Steroids and Their Synthetic Analogs: Inhibitors of the Synthesis and Actions of Adrenocortical Hormones","author":"Schimmer","year":"2006"},{"key":"10.1016\/j.amjmed.2010.09.012_bib20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","article-title":"Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjmed.2010.09.012_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/BOR.0b013e3282f524a2","article-title":"Lifestyle and gout","volume":"20","author":"Hak","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2010.09.012_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/BOR.0b013e3282f54d03","article-title":"We can make gout management more successful now","volume":"20","author":"Becker","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib24","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker?","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2010.09.012_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2010.09.012_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2010.09.012_bib27","series-title":"Chronic Kidney Disease 2006: A Guide to Select NKF-KDOQI Guidelines and Recommendations","author":"Bailie","year":"2006"},{"key":"10.1016\/j.amjmed.2010.09.012_bib28","first-page":"2050","article-title":"A survey of current evaluation and treatment of gout","volume":"33","author":"Schlesinger","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib30","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1001\/jama.1991.03470210072035","article-title":"Incidence and risk factors for gout in white men","volume":"266","author":"Roubenoff","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2010.09.012_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2010.09.012_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.rhu.0000147049.12220.32","article-title":"Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting","volume":"10","author":"Riedel","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib34","first-page":"13","article-title":"Therapeutic challenges in the management of gout in the elderly","volume":"63","author":"Singh","year":"2008","journal-title":"Geriatrics"},{"key":"10.1016\/j.amjmed.2010.09.012_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2165\/00002018-199411040-00004","article-title":"Risks and benefits of drugs used in the management and prevention of gout","volume":"11","author":"Conaghan","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjmed.2010.09.012_bib36","first-page":"1566","article-title":"Treatment of acute gout in hospitalized patients","volume":"34","author":"Petersel","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2010.09.012_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.22474","article-title":"Validity of gout diagnoses in administrative data","volume":"57","author":"Harrold","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2010.09.012_bib38","series-title":"Primer on the Rheumatic Diseases","first-page":"307","article-title":"Gout: epidemiology, pathology and pathogenesis","author":"Terkeltaub","year":"2001"},{"key":"10.1016\/j.amjmed.2010.09.012_bib39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00005650-199306000-00003","article-title":"Using claims data for epidemiologic research","volume":"31","author":"Quam","year":"1993","journal-title":"Med Care"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310009058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310009058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:54:13Z","timestamp":1757580853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934310009058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0002934310009058"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2010.09.012","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2010.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. Published by Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}